The last ten years have seen a notable increase in balloon pulmonary angioplasty safety.

Published Date: 23 Apr 2023

The treatment of chronic thromboembolic pulmonary hypertension with balloon pulmonary angioplasty has an evolving safety profile over the years, from 2013 to 2022, as revealed by an analysis of more than two dozen studies.

Read Full News

Latest News

Gossamer Bio Shares Plummet as Lung Disease Drug Fails Late-stage Trial

Gossamer Bio's experimental treatment failed to significantly improve exercise capacity in patients with a rare ⁠lung condition in a late-stage study, knocking the drug...

VALIANT: Verekitug Reduces Average Annual Asthma Flare-Ups in Phase 2 Trial

VALIANT: Verekitug Reduces Average Annual Asthma Flare-Ups in Phase 2 Trial

7 Pulmonology Headlines You Missed in January 2026

7 Pulmonology Headlines You Missed in January 2026

Elevated BDNF Linked to Depressive Symptoms in Patients with Asthma, With Hiroshi Iwamoto, MD, PhD

Elevated BDNF Linked to Depressive Symptoms in Patients with Asthma, With Hiroshi Iwamoto, MD, PhD

COPD Drug Withdrawal Tied to Early Exacerbation, With Alexander Mathioudakis, MD, PhD

COPD Drug Withdrawal Tied to Early Exacerbation, With Alexander Mathioudakis, MD, PhD

Treat Early, Treat Hard: Redefining the Modern PAH Treatment Paradigm Victoria Johnson

Pulmonary arterial hypertension treatment continues to evolve with new therapies and strategies.

Todays Updates

Older Adults With Advanced Cancer Prioritize Quality of Life

Most older adults with advanced cancer value quality of life over extending survival, but that preference may not translate to clinical care or outcomes.

Todays Updates

Older Adults With Advanced Cancer Prioritize Quality of Life

Most older adults with advanced cancer value quality of life over extending survival, but that preference may not translate to clinical care or outcomes.

Latest News

Gossamer Bio's experimental treatment failed to significantly improve exercise capacity in patients with a rare ⁠lung condition in a late-stage study, knocking the drug...

VALIANT: Verekitug Reduces Average Annual Asthma Flare-Ups in Phase 2 Trial

7 Pulmonology Headlines You Missed in January 2026

Elevated BDNF Linked to Depressive Symptoms in Patients with Asthma, With Hiroshi Iwamoto, MD, PhD

COPD Drug Withdrawal Tied to Early Exacerbation, With Alexander Mathioudakis, MD, PhD

Pulmonary arterial hypertension treatment continues to evolve with new therapies and strategies.

News All Time

5 Pulmonology Headlines You Missed in December 2025

5 Pulmonology Headlines You Missed in December 2025

Q4 2025 Recap: Pulmonology News and Updates

Q4 2025 Recap: Pulmonology News and Updates

Pulmonology in 2025: Year in Review

Pulmonology in 2025: Year in Review

Asthma in 2025: Year in Review

Asthma in 2025: Year in Review

COPD in 2025: Year in Review

COPD in 2025: Year in Review

Characterizing COPD - Lung Cancer Patients, with Joseph Friedberg, MD Joseph Friedberg, MD, Kevin Kunzmann

Friedberg discusses the inconsistent clinical pathways from disease progression to intervention in patients with a pair of highly deadly lung diseases.

Post-NICU PM2.5 Exposure Raises Asthma Risk in Children With Bronchopulmonary Dysplasia

Post-NICU PM2.5 Exposure Raises Asthma Risk in Children With Bronchopulmonary Dysplasia

Asthma Biologic Adherence Shaped by Psychological, Clinical, Systemic Factors

Asthma Biologic Adherence Shaped by Psychological, Clinical, Systemic Factors

FDA Approves Nerandomilast (Jascayd) Tablets for Progressive Pulmonary Fibrosis

FDA Approves Nerandomilast (Jascayd) Tablets for Progressive Pulmonary Fibrosis

Sleep Disorders Linked to Poorer Symptom Control in Severe Asthma

Sleep Disorders Linked to Poorer Symptom Control in Severe Asthma

FDA Approves Depemokimab-ulaa (Exdensur) for Severe Asthma

FDA Approves Depemokimab-ulaa (Exdensur) for Severe Asthma

Getting Through the Door: How COPD, Lung Cancer Screening Remains Minimal

Getting Through the Door: How COPD, Lung Cancer Screening Remains Minimal

Advancing NP and PA Involvement in Pulmonary Care, CHEST Learning Susan Corbridge, PhD, Alanna Kavanugh, MSN, CCRN

Susan Corbridge, PhD, and Alanna Kavannagh, MSN, CCRN, discuss the role of advanced practice providers on the evolving pulmonary and critical care teams during CHEST 2025.

Thunderstorms Linked to Surge in Asthma ER Visits

Thunderstorms Linked to Surge in Asthma ER Visits

House Dust Mite SLIT Tablet Well Tolerated in Children With Allergic Asthma

House Dust Mite SLIT Tablet Well Tolerated in Children With Allergic Asthma

5 Pulmonology Headlines You Missed in November 2025

5 Pulmonology Headlines You Missed in November 2025

Recommended News For You

The combination of nitedanib and prednisone reduces exacerbations of pulmonary diseases in radiative pneumonitis

I Understand Why Defense Secretary Austin Kept His Prostate Cancer Quiet.

What are the factors that cause oral mucositis to be severe after receiving radiation for head and neck cancer?

According to JAMA, statin use may increase cancer-related survival in breast cancer patients.

How to keep your prostate healthy and lower your risk of developing serious problems

Advanced breast cancer patients living longer thanks to improvements in treatment and care

In patients with advanced lung cancer, cemiplimab combined with chemotherapy extends life and enhances quality of life.

Recommended Articles For You

Landmark Medical Oncology Trials Redefining Early Breast Cancer Management 

The Cutting-Edge of Phlebectomy: Redefining Vein Care 

Mechanistic Insights into Abraxane, Verzenio, and the Management of Chemotherapy-Induced Tachycardia 

Breaking Down Leukocytoclastic Vasculitis: Causes, Symptoms and Treatment 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

the contribution of cortactin to the development of cancer.

2.

AI Model Has Promise for Predicting Checkpoint Inhibitor Activity in NSCLC

3.

Coffee, Tea Tied to Lower Risk of Head and Neck Cancer

4.

Cancer Vaccines' Emergence; More Focus on Side Effects; A Nudge for Exercise.

5.

New tumor therapy approach reduces costs and side effects while increasing accessibility

1.

Breaking Barriers in Cancer Treatment: The Role of Innovative Oncology Drugs

2.

Cancer Diagnosis in 2025: Innovations, Education, and Evolving Clinical Strategies

3.

How Digital Innovation and AI-Powered Case Studies are Revolutionizing Oncology Education?

4.

What You Need to Know About the Early Warning Signs of Colon Cancer 

5.

Decoding Hamartomas: Understanding Their Causes and Symptoms

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

2.

Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC

3.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII

4.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

5.

Preventing Blood Clots: The Importance of Venous Thromboembolism Management

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot